Rise Advisors’s Universal Health Services UHS Stock Holding History

Rise Advisors’s Portfolio UHS Stock Details UHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9	Closed	-$1.84K	–	1344
2025 Q3	$1.84K	Buy	9 +6	+200%	+$1.08K	﹤0.01%	1198
2025 Q2	$543	Hold	3	–	–	﹤0.01%	1396
2025 Q1	$564	Buy	+3	New	+$547	﹤0.01%	1355

Other funds holding UHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Rise Advisors's UHS Position: Q4 2025 in Review

Rise Advisors sold out of Universal Health Services (UHS) in Q4 2025, closing a stake of 9 shares — an estimated $1.84K sold.

Rise Advisors first reported a position in UHS in Q1 2025 and held it in 3 quarters. The position peaked at $1.84K in Q3 2025. 689 funds tracked by Wall St. Rank hold UHS as of Q4 2025.

Rise Advisors reported no remaining Universal Health Services position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 9 Universal Health Services shares in Q4 2025, an estimated $1.84K.
Rise Advisors first reported a position in Universal Health Services in Q1 2025 and held it in 3 quarters.
Rise Advisors's Universal Health Services position peaked at $1.84K in Q3 2025.
689 funds tracked by Wall St. Rank held Universal Health Services as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.